Skip to Main Content

Rise and shine, everyone, another busy day is on the way, although the Pharmalot campus has quieted down somewhat now that the shortest person has left for the local schoolhouse and the official mascots are quartered in doggie daycare for a while. All of which makes it easier for us to pursue the usual routine which, of course, includes cups of stimulation. We are back to Southern Pecan, for those who care. Anyway, here are your tidbits. Have a lovely day and, as always, please do keep in touch. We enjoy documents, emails, texts, and postcards …

Mylan chairman Robert Coury received nearly $100 million last year, among the largest pay packages disclosed this year for any public company, even as the drug maker was harshly criticized over hefty price increases on EpiPen, The Wall Street Journal notes. He also received an additional $66.3 million in retirement benefits and other payments in connection with his transition from executive chairman to a non-employee chairman role (read the proxy here).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!